A New Hope in the Treatment of Intraventricular Haemorrhage in Preterm Infants: Mesenchymal Stem Cells
Turkish Neurosurgery, cilt.32, sa.5, ss.882, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Kısa Makale
- Cilt numarası: 32 Sayı: 5
- Basım Tarihi: 2022
- Doi Numarası: 10.5137/1019-5149.jtn.40427-22.2
- Dergi Adı: Turkish Neurosurgery
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
- Sayfa Sayıları: ss.882
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
To the Editor, We read with interest Bozkaya et al. (1) article about a male preterm infant with Germinal matrix-intraventricular hemorrhage (GM-IVH), who recovered after MSC’s transplantation. GM-IVH is the most serious complication of premature birth. It is known that bleeding originates from capillaries in the germinal matrix that have not fully developed. 25–50% of the GM-IVH cases are asymptomatic (2). In patients with significant GM-IVH, the patient’s neurological status may be very poor. The most important outcomes of the GM-IVH are periventricular hemorrhagic infarction and post-hemorrhagic hydrocephalus (PHH). The prognosis of bleeding is related to its amount and damage to brain tissue. The major points in this process is thought to be related to the presence and degree of infarct areas around the ventricle (2).